A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.
暂无分享,去创建一个
L. Peltonen | V. Salomaa | M. Perola | M. Nieminen | Amitabh Sharma | S. Ripatti | S. Kathiresan | O. Melander | M. Orho-Melander | C. Guiducci | A. Havulinna | K. Silander | A. Jula | E. Tikkanen | M. Lokki | J. Sinisalo
[1] Veikko Salomaa,et al. Thirty-five-year trends in cardiovascular risk factors in Finland. , 2010, International journal of epidemiology.
[2] Nancy R Cook,et al. Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.
[3] Michael J Pencina,et al. Reclassification calculations for persons with incomplete follow-up. , 2010, Annals of internal medicine.
[4] R. Collins,et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.
[5] M. Pencina,et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.
[6] Daniel F. Schwarz,et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3 , 2009, Nature Genetics.
[7] D. Postma,et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction , 2009, Nature Genetics.
[8] Alberto Piazza,et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.
[9] Xiao-Hua Zhou,et al. Statistical Methods for Meta‐Analysis , 2008 .
[10] Olle Melander,et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. , 2008, The New England journal of medicine.
[11] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[12] Nancy R Cook,et al. Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929) , 2008, Statistics in medicine.
[13] Ho-Cheol Kang,et al. Images in clinical medicine. Peripheral artery disease. , 2007, The New England journal of medicine.
[14] Kari Stefansson,et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. , 2007, Science.
[15] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[16] A. Gylfason,et al. A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.
[17] V. Salomaa,et al. The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[18] G. Berglund,et al. Elevated Lp-PLA2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[19] Jonathan C. Cohen,et al. A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.
[20] J. Ware. The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.
[21] D. Healy. Case-control studies in the genomic era: a clinician's guide , 2006, The Lancet Neurology.
[22] V. Salomaa,et al. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. , 2006, European heart journal.
[23] V. Salomaa,et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[24] Laura Antolini,et al. Inference on Correlated Discrimination Measures in Survival Analysis: A Nonparametric Approach , 2004 .
[25] T. Lumley,et al. Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.
[26] G. Berglund,et al. Design and feasibility , 1993 .
[27] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .
[28] W. Kannel,et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.
[29] B. Gersh,et al. Thirty-five-year trends in cardiovascular risk factors in Finland , 2011 .
[30] S. Heistaro. Methodology report : Health 2000 survey , 2008 .
[31] Bryan Langholz,et al. Risk set sampling in epidemiologic cohort studies , 1996 .
[32] G. Berglund,et al. The Malmo Diet and Cancer Study. Design and feasibility. , 1993, Journal of internal medicine.
[33] M. Vervenne. On Methodology. A Report , 1991 .